Sanofi, Access Industries and Alphabet helped Areteia Therapeutics raise $350m, and Nordisk Games acquires Supermassive Games.

Funding
US-based asthma therapy developer Areteia Therapeutics has raised $350m from investors including pharmaceutical firm Sanofi, internet and technology group Alphabet’s GV subsidiary and Access Biotechnology, part of conglomerate Access Industries. The round was led by private equity firm Bain Capital through its Bain Capital Life Sciences fund, while Arch Venture Partners, Saturn Partners, M...

Please login to access this content. Not a subscriber? Click below to view your membership options.

Subscription Options

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?